drugset
drugset / Trial / NCT03574805

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

NCT03574805 ↗

Phase 1 Completed 76 enrolled Pieris Australia Pty Ltd
RandomizedParallel-groupSingle-blindTreatment

Summary

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects with Mild Asthma

Timeline

Start
2018-06-26
Primary completion
2020-09-15
Completion
2020-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Elarekibep Protein / enzyme biologic — Other

Indications

asthma